Multidimensional Risk Factor Assessment in Constipation
NCT ID: NCT02884167
Last Updated: 2017-12-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
170 participants
OBSERVATIONAL
2016-06-30
2017-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The overall aim of this study is to investigate the multidimensional (physiological, environmental and demographic) predictors of constipation with the use of a multivariate analysis statistical model.
This is a large single centre case control study comparing constipated adults with healthy individuals matched for age, gender and ethnicity.
The duration of the study is 2 weeks in total and includes a screening visit, a 2 week run-in period and a baseline visit at the end of the run-in period. Transit time between constipated and healthy individuals is assessed at baseline visit. Differences in gastrointestinal symptoms, dietary intake as well as differences in stool output (e.g. stool frequency and consistency) between constipated and healthy individuals are assessed over the baseline period (the week before the baseline visit). Differences in female sex hormone levels as well as stool markers and markers of fermentation (e.g. fecal water, stool pH, short chain fatty acids) between constipated and healthy individuals are assessed at baseline visit. Furthermore, differences in environmental measures (physical activity, anxiety, smoking) and differences in demographic measures (age, gender, body mass index) between patients suffering from constipation and healthy individuals are also assessed at baseline visit.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with constipation
No interventions assigned to this group
Healthy individuals without constipation
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Symptoms of constipation for a minimum of 3 months
* Recruitment based on simplified core ROME III diagnostic criteria for functional constipation
* Average Bristol stool type of 1-4 AND frequency of 1-3 spontaneous bowel movements per week
* Cleveland Clinic constipation score (CCCS) of 8-15
* Adult men or women (18-65 years)
* Healthy individuals without any coexisting acute or chronic disease
* Not meeting simplified core ROME III diagnostic criteria for functional constipation
* Average Bristol stool type of 2-5 AND frequency of 3-21 spontaneous bowel movements per week
* Cleveland Clinic constipation score (CCCS) of \< 8
Exclusion Criteria
* Ongoing other diagnosed gastrointestinal disease or complication
* Alarm features such as sudden weight loss, rectal bleeding, recent change in bowel habit (\<3 months), abdominal pain and stool positive for occult blood
* Prior GI surgery except cholecystectomy, appendicectomy and simple vaginal hysterectomy
* Neurologic diseases
* Ongoing therapy with drugs known to affect gut motility
* Subjects with comorbid illnesses such as cardiovascular, endocrine, renal or other chronic disease likely to affect gut motility or limit normal functions
* Self-reported symptoms of pelvic organ prolapse
* Moderate or severe active local anorectal problems
* Incapacity to consent
* Aged under 18 or over 65 years
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Queen Mary University of London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Queen Mary University of London
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ReDA-010666 QM
Identifier Type: -
Identifier Source: org_study_id